Search

Your search keyword '"Fernando Civeira"' showing total 470 results

Search Constraints

Start Over You searched for: Author "Fernando Civeira" Remove constraint Author: "Fernando Civeira"
470 results on '"Fernando Civeira"'

Search Results

1. PCSK9 inhibitors on the management of primary and secondary cardiovascular prevention

2. OptiMo‐LDLr: An Integrated In Silico Model with Enhanced Predictive Power for LDL Receptor Variants, Unraveling Hot Spot Pathogenic Residues

3. Current causes of death in familial hypercholesterolemia

4. An elevated parametric thyroid feedback quantile-based index is associated with atrial fibrillation

5. High consumption of ultra-processed food may double the risk of subclinical coronary atherosclerosis: the Aragon Workers’ Health Study (AWHS)

6. Obtaining evidence base for the development of Feel4Diabetes intervention to prevent type 2 diabetes – a narrative literature review

7. Two-stage, school and community-based population screening successfully identifies individuals and families at high-risk for type 2 diabetes: the Feel4Diabetes-study

8. Comparative efficacy between atorvastatin and rosuvastatin in the prevention of cardiovascular disease recurrence

9. APOE Genotypes Modulate Inflammation Independently of Their Effect on Lipid Metabolism

10. Effect of the Consumption of Alcohol-Free Beers with Different Carbohydrate Composition on Postprandial Metabolic Response

11. Association between non-cholesterol sterol concentrations and Achilles tendon thickness in patients with genetic familial hypercholesterolemia

12. Cataract Surgery in Elderly Subjects with Heterozygous Familial Hypercholesterolemia in Prolonged Treatment with Statins

13. SR-B1, a Key Receptor Involved in the Progression of Cardiovascular Disease: A Perspective from Mice and Human Genetic Studies

14. Effect of LDL cholesterol, statins and presence of mutations on the prevalence of type 2 diabetes in heterozygous familial hypercholesterolemia

15. Effect of Lifestyle Intervention in the Concentration of Adipoquines and Branched Chain Amino Acids in Subjects with High Risk of Developing Type 2 Diabetes: Feel4Diabetes Study

16. Lipid Profile Rather Than the LCAT Mutation Explains Renal Disease in Familial LCAT Deficiency

17. Efficacy and Safety of Alirocumab 150 mg Every 4 Weeks in Patients With Hypercholesterolemia Not on Statin Therapy: The ODYSSEY CHOICE II Study

19. The genetic basis of familial hypercholesterolemia: inheritance, linkage, and mutations

20. FABP4 plasma levels are increased in familial combined hyperlipidemia

21. Glycated Hemoglobin, Fasting Insulin and the Metabolic Syndrome in Males. Cross-Sectional Analyses of the Aragon Workers' Health Study Baseline.

23. Implantación de un programa de cribado bioquímico y genético de hipercolesterolemia familiar. Colaboración entre el laboratorio clínico y las unidades de lípidos: diseño del Proyecto ARIAN

24. Lipoprotein(a) and Benefit of PCSK9 Inhibition in Patients With Nominally Controlled LDL Cholesterol

25. El hospital universitario del siglo XXI

26. Apolipoprotein B, Residual Cardiovascular Risk After Acute Coronary Syndrome, and Effects of Alirocumab

27. 859 - DESCRIPCIÓN DEL IMPACTO DE LA DISMINUCIÓN DE LOS LÍPIDOS EN LA COMPOSICIÓN DE LA PLACA DE ATEROMA VALORADO POR ECOGRAFÍA BIDIMENSIONAL

28. Contribution of APOE Genetic Variants to Dyslipidemia

35. Diagnosis of Familial Dysbetalipoproteinemia Based on the Lipid Abnormalities Driven by APOE2/E2 Genotype

37. A mechanism-based operational definition and classification of hypercholesterolemia

40. Implantación de un programa de cribado bioquímico y genético de hipercolesterolemia familiar. Colaboración entre el laboratorio clínico y las unidades de lípidos: diseño del Proyecto ARIAN

41. MLb-LDLr

42. Apolipoprotein B, Residual Cardiovascular Risk After Acute Coronary Syndrome, and Effects of Alirocumab

43. Hipercolesterolemia familiar en Gran Canaria: mutación con efecto fundador y alta frecuencia de diabetes

44. Rendimiento diagnóstico de la secuenciación de genes de hipercolesterolemia familiar en sujetos con hipercolesterolemia primaria

45. Leu22_Leu23 Duplication at the Signal Peptide of PCSK9 Promotes Intracellular Degradation of LDLr and Autosomal Dominant Hypercholesterolemia

46. Disbetalipoproteinemia y otras alteraciones relacionadas con la apolipoproteína E

47. Carga de enfermedad. Cálculo del riesgo cardiovascular y objetivos terapéuticos

48. Triglyceride Metabolism Modifies Lipoprotein(a) Plasma Concentration

49. Maternally inherited hypercholesterolemia does not modify the cardiovascular phenotype in familial hypercholesterolemia

50. Glycerol kinase deficiency in adults: Description of 4 novel cases, systematic review and development of a clinical diagnostic score

Catalog

Books, media, physical & digital resources